The relationship between levels of tumor necrosis factor-alpha, interleukin-6, and C-reactive protein in the serum of elderly and acute myocardial infarction
This study aimed to explore the relationship between the serum levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and hypersensitive C-reactive protein (hs-CRP) and the prognosis of acute myocardial infarction (AMI) patients after percutaneous coronary intervention (PCI) treatment. A total of 118 early-onset AMI patients who successfully received PCI (in the PCI group, blood samples were collected before PCI, 12, 24, 48 h after PCI, and 90 d follow-up period) and 52 AMI patients who received only cardioangiography (CAG) (in the CAG group, blood samples were collected before CAG, 12, 24, 48 h after CAG, and 9...
Source: Mol Biol Cell - April 28, 2024 Category: Molecular Biology Authors: Jinlong Miao Tao Du Source Type: research
Drug-coated balloon in the treatment of coronary artery de-novo large lesions angiography
Cell Mol Biol (Noisy-le-grand). 2024 Apr 28;70(4):196-201. doi: 10.14715/cmb/2024.70.4.31.ABSTRACTThe superiority of drug-coated balloon (DCB) in treating small vessels, branching lesions, and high-risk bleeding lesions in coronary heart disease patients has been confirmed. However, its safety and efficacy in large vessels are still unclear. We aimed to investigate whether the efficacy of DCB in large vessels is not inferior to that of drug-eluting stent (DES). From November 2019 to April 2022, a total of 88 patients in our hospital who underwent coronary angiography for the first time and decided to receive DCB or DES tre...
Source: Cellular and Molecular Biology - April 28, 2024 Category: Molecular Biology Authors: Xingyou Cai Xin Hong Yuli Wang Yafei Li Guidong Xu Source Type: research
The relationship between levels of tumor necrosis factor-alpha, interleukin-6, and C-reactive protein in the serum of elderly and acute myocardial infarction
This study aimed to explore the relationship between the serum levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and hypersensitive C-reactive protein (hs-CRP) and the prognosis of acute myocardial infarction (AMI) patients after percutaneous coronary intervention (PCI) treatment. A total of 118 early-onset AMI patients who successfully received PCI (in the PCI group, blood samples were collected before PCI, 12, 24, 48 h after PCI, and 90 d follow-up period) and 52 AMI patients who received only cardioangiography (CAG) (in the CAG group, blood samples were collected before CAG, 12, 24, 48 h after CAG, and 9...
Source: Cellular and Molecular Biology - April 28, 2024 Category: Molecular Biology Authors: Jinlong Miao Tao Du Source Type: research
Drug-coated balloon in the treatment of coronary artery de-novo large lesions angiography
Cell Mol Biol (Noisy-le-grand). 2024 Apr 28;70(4):196-201. doi: 10.14715/cmb/2024.70.4.31.ABSTRACTThe superiority of drug-coated balloon (DCB) in treating small vessels, branching lesions, and high-risk bleeding lesions in coronary heart disease patients has been confirmed. However, its safety and efficacy in large vessels are still unclear. We aimed to investigate whether the efficacy of DCB in large vessels is not inferior to that of drug-eluting stent (DES). From November 2019 to April 2022, a total of 88 patients in our hospital who underwent coronary angiography for the first time and decided to receive DCB or DES tre...
Source: Cellular and Molecular Biology - April 28, 2024 Category: Molecular Biology Authors: Xingyou Cai Xin Hong Yuli Wang Yafei Li Guidong Xu Source Type: research
The relationship between levels of tumor necrosis factor-alpha, interleukin-6, and C-reactive protein in the serum of elderly and acute myocardial infarction
This study aimed to explore the relationship between the serum levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and hypersensitive C-reactive protein (hs-CRP) and the prognosis of acute myocardial infarction (AMI) patients after percutaneous coronary intervention (PCI) treatment. A total of 118 early-onset AMI patients who successfully received PCI (in the PCI group, blood samples were collected before PCI, 12, 24, 48 h after PCI, and 90 d follow-up period) and 52 AMI patients who received only cardioangiography (CAG) (in the CAG group, blood samples were collected before CAG, 12, 24, 48 h after CAG, and 9...
Source: Cellular and Molecular Biology - April 28, 2024 Category: Molecular Biology Authors: Jinlong Miao Tao Du Source Type: research
Drug-coated balloon in the treatment of coronary artery de-novo large lesions angiography
Cell Mol Biol (Noisy-le-grand). 2024 Apr 28;70(4):196-201. doi: 10.14715/cmb/2024.70.4.31.ABSTRACTThe superiority of drug-coated balloon (DCB) in treating small vessels, branching lesions, and high-risk bleeding lesions in coronary heart disease patients has been confirmed. However, its safety and efficacy in large vessels are still unclear. We aimed to investigate whether the efficacy of DCB in large vessels is not inferior to that of drug-eluting stent (DES). From November 2019 to April 2022, a total of 88 patients in our hospital who underwent coronary angiography for the first time and decided to receive DCB or DES tre...
Source: Cellular and Molecular Biology - April 28, 2024 Category: Molecular Biology Authors: Xingyou Cai Xin Hong Yuli Wang Yafei Li Guidong Xu Source Type: research
The relationship between levels of tumor necrosis factor-alpha, interleukin-6, and C-reactive protein in the serum of elderly and acute myocardial infarction
This study aimed to explore the relationship between the serum levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and hypersensitive C-reactive protein (hs-CRP) and the prognosis of acute myocardial infarction (AMI) patients after percutaneous coronary intervention (PCI) treatment. A total of 118 early-onset AMI patients who successfully received PCI (in the PCI group, blood samples were collected before PCI, 12, 24, 48 h after PCI, and 90 d follow-up period) and 52 AMI patients who received only cardioangiography (CAG) (in the CAG group, blood samples were collected before CAG, 12, 24, 48 h after CAG, and 9...
Source: Cellular and Molecular Biology - April 28, 2024 Category: Molecular Biology Authors: Jinlong Miao Tao Du Source Type: research
The Current State of Hybrid Coronary Revascularization
Ann Thorac Surg. 2024 Apr 25:S0003-4975(24)00299-6. doi: 10.1016/j.athoracsur.2024.04.010. Online ahead of print.ABSTRACTHybrid coronary revascularization (HCR) combines a minimally invasive surgical approach with percutaneous coronary intervention (PCI) for the treatment of multi-vessel coronary artery disease. Despite decades of use, widespread acceptance has been limited. In this review, we conduct a comparative assessment of HCR in relation to traditional coronary artery bypass graft surgery and multi-vessel PCI. While large scale randomized data is still lacking, numerous studies have demonstrated that HCR may offer b...
Source: The Annals of Thoracic Surgery - April 27, 2024 Category: Cardiovascular & Thoracic Surgery Authors: Robin Willard Joshua Scheinerman Stevan Pupovac Nirav C Patel Source Type: research
The Current State of Hybrid Coronary Revascularization
Ann Thorac Surg. 2024 Apr 25:S0003-4975(24)00299-6. doi: 10.1016/j.athoracsur.2024.04.010. Online ahead of print.ABSTRACTHybrid coronary revascularization (HCR) combines a minimally invasive surgical approach with percutaneous coronary intervention (PCI) for the treatment of multi-vessel coronary artery disease. Despite decades of use, widespread acceptance has been limited. In this review, we conduct a comparative assessment of HCR in relation to traditional coronary artery bypass graft surgery and multi-vessel PCI. While large scale randomized data is still lacking, numerous studies have demonstrated that HCR may offer b...
Source: The Annals of Thoracic Surgery - April 27, 2024 Category: Cardiovascular & Thoracic Surgery Authors: Robin Willard Joshua Scheinerman Stevan Pupovac Nirav C Patel Source Type: research
The Current State of Hybrid Coronary Revascularization
Ann Thorac Surg. 2024 Apr 25:S0003-4975(24)00299-6. doi: 10.1016/j.athoracsur.2024.04.010. Online ahead of print.ABSTRACTHybrid coronary revascularization (HCR) combines a minimally invasive surgical approach with percutaneous coronary intervention (PCI) for the treatment of multi-vessel coronary artery disease. Despite decades of use, widespread acceptance has been limited. In this review, we conduct a comparative assessment of HCR in relation to traditional coronary artery bypass graft surgery and multi-vessel PCI. While large scale randomized data is still lacking, numerous studies have demonstrated that HCR may offer b...
Source: The Annals of Thoracic Surgery - April 27, 2024 Category: Cardiovascular & Thoracic Surgery Authors: Robin Willard Joshua Scheinerman Stevan Pupovac Nirav C Patel Source Type: research
The Current State of Hybrid Coronary Revascularization
Ann Thorac Surg. 2024 Apr 25:S0003-4975(24)00299-6. doi: 10.1016/j.athoracsur.2024.04.010. Online ahead of print.ABSTRACTHybrid coronary revascularization (HCR) combines a minimally invasive surgical approach with percutaneous coronary intervention (PCI) for the treatment of multi-vessel coronary artery disease. Despite decades of use, widespread acceptance has been limited. In this review, we conduct a comparative assessment of HCR in relation to traditional coronary artery bypass graft surgery and multi-vessel PCI. While large scale randomized data is still lacking, numerous studies have demonstrated that HCR may offer b...
Source: The Annals of Thoracic Surgery - April 27, 2024 Category: Cardiovascular & Thoracic Surgery Authors: Robin Willard Joshua Scheinerman Stevan Pupovac Nirav C Patel Source Type: research
Effectiveness of late coronary angioplasty in restoring sinus rhythm in inferior wall myocardial infarction with complete AV block
Coronary angiogram done with temporary pacemaker support showing a proximally occluded right coronary artery. AbstractAn elderly gentleman presenting late with inferior wall myocardial infarction and complete heart block underwent revascularization of an occluded proximal right coronary artery more than 4 days after the onset of symptoms and recovered sinus rhythm within 48 h of the procedure. There are no clear guidelines for time to percutaneous coronary intervention (PCI) in late-presenting myocardial infarction with complete atrioventricular blocks (CAVB), and studies looking at outcomes of primary PCI in this sit...
Source: Clinical Case Reports - April 27, 2024 Category: General Medicine Authors: Avitso Liegise,
Lanu Naro Tags: CASE REPORT Source Type: research
Revascularizing Multivessel Coronary Artery Disease in Acute Coronary Syndromes: Choices and Questions
Acute coronary syndrome (ACS) is a leading cause of hospital admissions and mortality worldwide1. Revascularization of coronary artery disease (CAD) has been shown to improve cardiovascular outcomes including mortality in this patient population2. When a clear, single vessel culprit coronary artery lesion is identified on invasive coronary angiography, then the revascularization decision is straightforward with percutaneous coronary intervention (PCI) as the best option3. However, approximately 50% of patients presenting with ACS are found to have multivessel CAD, and then the decision on which revascularization strategy t...
Source: The American Journal of Cardiology - April 27, 2024 Category: Cardiology Authors: Rafic F. Berbarie Tags: Editorial Source Type: research
Improvement of coronary stent visualization using ultra-high-resolution photon-counting detector CT
ConclusionUHR CCTA by PCD-CT leads to significantly improved visualization and diagnostic performance of coronary stents, and Bv72 is the optimal reconstruction kernel showing the stent struts and in-stent lumen.Clinical relevance statementThe significantly improved visualization of coronary stents using ultra-high resolution CCTA could increase the diagnostic accuracy for in-stent restenosis and avoid unnecessary invasive quantitative coronary angiography, thus changing the clinical management for patients after percutaneous coronary intervention.Key PointsCoronary stent imaging is challenging with energy-integrating dete...
Source: European Radiology - April 27, 2024 Category: Radiology Source Type: research
Characteristics of Patients Undergoing High-Risk Percutaneous Coronary Intervention in Contemporary United States Practice
There is no universally accepted definition of high-risk percutaneous coronary intervention (HRPCI), nor is there consensus regarding when to use mechanical circulatory support (MCS) during HRPCI. Expert consensus on HRPCI have suggested considering the presence of three distinct entities in the decision to use MCS: complexity of coronary anatomy/ lesion characteristics, patient comorbidities, and adverse hemodynamics1. Although the use of MCS during HRPCI has increased significantly over the past decade (27-fold increase in annual number from 2008 to 2018)2, little is known regarding the detailed characteristics of these ...
Source: The American Journal of Cardiology - April 26, 2024 Category: Cardiology Authors: Aditya S. Bharadwaj, Alexander G. Truesdell, Alejandro Lemor, Julia B. Thompson, Arsalan Abu-Much, Yiran Zhang, Michael J. Schonning, David J. Cohen, Alexandra J. Lansky, William W. O'Neill Tags: Brief report Source Type: research
